Evaluation of microRNA expression levels during the craving period of patients diagnosed with severe alcohol use disorder

dc.contributor.authorAsçibasi, K
dc.contributor.authorDeveci, A
dc.contributor.authorÖzyilmaz, B
dc.contributor.authorErdogan, KM
dc.contributor.authorÇakiroglu, E
dc.date.accessioned2024-07-18T12:02:44Z
dc.date.available2024-07-18T12:02:44Z
dc.description.abstractBackgroundThe aim of this study is to compare the serum MicroRNA (miRNA) expression levels on the first day of hospitalization and at the end of the first month of treatment in patients with alcohol use disorder and severe craving symptoms. Through the obtained data, biological agents targeting microRNA for alcohol craving may be developed.MethodsThe volunteer group consists of four patients diagnosed with severe alcohol use disorder. Sociodemographic and Clinical Information Form, DSM-5 Structured Clinical Interview-Clinical Version (SCID-5-CV), Penn Alcohol Craving Scale (PACS) were used as clinical assessment tools. Peripheral blood samples were obtained at the time of application and on the 30th day. miRNA isolation was performed. The expression levels of 2578 different mature human miRNAs were measured.ResultsThe miRNAs showing statistically significant differences in peripheral blood samples taken on the 1st and 30th days from alcohol users are as follows: miR-19a-3p, miR-6849-5p, miR-6726-5p, miR-6848-5p, miR-186-5p, miR-6889-5p, miR-933, miR-370-3p, miR-5739, miR-103a-2-5p, miR-6860, miR-1254, miR-1260a, miR-3921, miR-127-3p, miR-8064, miR-6870-5p, miR-4688ConclusionsA significant difference was found between the 1st and 30th days in 18 of 2578 miRNAs scanned. It is aimed to investigate these 18 miRNAs in larger sample groups during the alcohol craving period.
dc.identifier.issn1465-9891
dc.identifier.other1475-9942
dc.identifier.urihttp://akademikarsiv.cbu.edu.tr:4000/handle/123456789/8653
dc.language.isoEnglish
dc.publisherTAYLOR & FRANCIS INC
dc.subjectSYNTHASE KINASE 3-BETA
dc.subjectDORSOMEDIAL STRIATUM
dc.subjectSYNAPTIC PLASTICITY
dc.subjectNMDA RECEPTORS
dc.subjectDRINKING
dc.subjectCONSUMPTION
dc.subjectGENETICS
dc.subjectSEEKING
dc.subjectDRUGS
dc.titleEvaluation of microRNA expression levels during the craving period of patients diagnosed with severe alcohol use disorder
dc.typeArticle; Early Access

Files